Fluorine News and Research

RSS
Radioactive tracer with PET MRI imaging helps prostate cancer patients avoid unnecessary surgery

Radioactive tracer with PET MRI imaging helps prostate cancer patients avoid unnecessary surgery

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

New "18F radiotracers" to detect and track certain diseases in patients

New "18F radiotracers" to detect and track certain diseases in patients

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

New Dartmouth study finds many people unnecessarily fear low amounts of chemicals in their food

New Dartmouth study finds many people unnecessarily fear low amounts of chemicals in their food

Perfluoroalkyl substances are crossing blood brain barrier of polar bears

Perfluoroalkyl substances are crossing blood brain barrier of polar bears

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Researchers develop new PET tracer to better monitor the progress of cancer and cancer therapy

Researchers develop new PET tracer to better monitor the progress of cancer and cancer therapy

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

Pelchem and Linde team up to advance MEMS systems

Pelchem and Linde team up to advance MEMS systems

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells

Study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells

Study shows how theranostic nanoparticles can effectively deliver cancer drugs to tumour cells

Study shows how theranostic nanoparticles can effectively deliver cancer drugs to tumour cells

Combination of imaging and biomarker tests helps predict Alzheimer's in patients with MCI

Combination of imaging and biomarker tests helps predict Alzheimer's in patients with MCI

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

Cardinal Health to produce new AD diagnostic imaging agent, Amyvid

Cardinal Health to produce new AD diagnostic imaging agent, Amyvid